Cingulate_Logo_400x400_twitter.jpg
Cingulate Receives Guidance from FDA on Path Forward for Anxiety Asset CTx-2103 (buspirone)
01 déc. 2023 09h00 HE | Cingulate Inc.
KANSAS CITY, Kan., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
Lifeist Wellness
Mikra Successfully Launches Serenity, an Innovative Mental Health Product for Anxiety
30 nov. 2023 07h00 HE | Lifeist Wellness Inc.
TORONTO, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in...
Mikra Serenity GCMS Verified Dietary Supplement for the Relief of Anxiety
Mikra Receives First Shipment of Serenity, an Innovative Mental Health Product for Anxiety, in Time for Black Friday
22 nov. 2023 07h00 HE | Lifeist Wellness Inc.
TORONTO, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in...
Helping Children and
Helping Children and Adolescents with Emotional Problems: Free Webinar for Parents and Educators from the Brain & Behavior Research Foundation
16 nov. 2023 13h00 HE | Brain & Behavior Research Foundation
New York, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Children’s mental health is a major concern and improving the potential for early intervention is essential. The Brain & Behavior Research Foundation...
Lifeist.png
Mikra Introduces Serenity, an Innovative Mental Health Product for Anxiety, Available for Purchase on Black Friday
16 nov. 2023 07h00 HE | Lifeist Wellness Inc.
Serenity, a natural supplement based on the proven extract of lavender oil, will be available for sale on Black Friday (November 23, 2023) at weareMikra.com TORONTO, Nov. 16, 2023 (GLOBE NEWSWIRE)...
Cingulate_Logo_400x400_twitter.jpg
Cingulate Inc. Reports Third Quarter 2023 Financial Results and Provides Clinical and Business Update
13 nov. 2023 16h15 HE | Cingulate Inc.
Phase 3 Adult Efficacy and Safety Trial Data Presented at Psych Congress Cingulate Closed a $4M Public Offering $5.8M of Debt Converted into CING Equity KANSAS CITY, Kan., Nov. 13, 2023 (GLOBE...
Lifeist.png
Lifeist's Mikra Completes Formulation of Innovative Mental Health Product for Anxiety 
02 nov. 2023 07h00 HE | Lifeist Wellness Inc.
Mikra introduces Serenity, a new innovative product based on an extract of lavender oil aimed at supporting mental health
Cingulate_Logo_400x400_twitter.jpg
Cingulate to Host CNS Key Opinion Leader Panel in New York City
17 oct. 2023 14h22 HE | Cingulate Inc.
KANSAS CITY, Kan., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
MDbio_Logo.png
Groundbreaking Study Finds Natural Formulation by MDbio – The Doctors BrandTM Significantly Improves Sleep, Anxiety, Stress, and Overall Well-being
03 oct. 2023 09h00 HE | MDbio
Los Angeles, CA, Oct. 03, 2023 (GLOBE NEWSWIRE) -- In a momentous large-scale clinical trial, a MDSleep formulation by MDbio – The Doctors BrandTM was proven to significantly improve sleep compared...
Lifeist.png
Lifeist's Mikra Introduces Innovative New Mental Health Product and Provides Corporate Update
26 sept. 2023 07h00 HE | Lifeist Wellness Inc.
TORONTO, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in...